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ABSTRACT 
 
Loss-of-function approaches are important tools for functional gene analysis. Due to the availability of sophis-
ticated methods to manipulate gene expression in embryonic stem cells that can be used to generate mutant 
mice, the mouse is by far the most important vertebrate model organism for basic and applied biomedical re-
search. Unfortunately, the available methods do not allow for precise temporal and spatial control of gene si-
lencing during embryonic development limiting the usefulness of the mouse for developmental studies. Due to 
their easy accessibility chicken embryos have been one of the preferred model organisms for developmental 
studies. Their disadvantage, the lack of genetic tools, could be overcome by the development of in ovo RNAi 
(in ovo RNA interference), a method that allows for temporal and spatial control of gene silencing in vivo. 
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INTRODUCTION 
 
Methods of gene silencing are important tools with appli-
cations from basic research to drug development and ther-
apy. Different needs in these fields of applications have 
brought forth different solutions. Due to the possibilities to 
block  gene  function  in  large-scale  screens  invertebrates 
were  the  model  organisms  of  choice  for  the  molecular 
analysis  of  physiological  and  developmental  processes 
(Friedman and Perrimon, 2004). In so-called forward ge-
netic screens mutagens were used to randomly mutate ge-
nomes  of  flies  and  worms. The resulting  phenotypes  of 
interest were selected and the genes containing the muta-
tion  causing  these  phenotypes  were  identified.  Unfortu-
nately, the elegance of these forward genetic screens can-
not be transferred to reverse genetics in these organisms. It 
is much more difficult to cause a mutation in a specific 
target gene and then look at the consequences of this muta-
tion. However,  reverse  genetics is  required  to  study  the 
role of genes in a given context or to study gene function 
in vertebrates, where forward genetic screens are largely 
restricted to zebrafish. Although there are attempts to ap-
ply  forward  genetics  to  mice  the  high  cost  and  the  re-
quirement  for  large  space  will  keep  their  numbers  low 
(Carlson and Largaespada, 2005; Kile and Hilton, 2005). 
Many questions, for instance in organogenesis or neurobi-
ology, cannot be studied in invertebrates and require the 
analysis of gene function in vertebrates. The mouse has 
become the model organism of choice for the majority of 
questions in basic and biomedical research. Mice are easy 
to breed and house in a lab environment. For many aspects 
of human physiology and disease there would be a better 
model than the mouse but none of them offers a compara-
ble toolkit for gene manipulations. Because mice can be 
reconstituted from embryonic stem (ES) cells that can be 
manipulated in culture sophisticated manipulations of the 
mouse genome are possible (for a recent review see Glaser 
et al, 2005). Still, there are limitations in using the mouse 
as a model when it comes to developmental studies. Due 
to the inaccessibility of mammals during gestation ovipa-
rous animals, i.e. fish, reptiles, and birds, are much easier 
to use for experimental manipulations in vivo. Their em-
bryonic development is very similar and directly compara-
ble to mammals, at least for those animals that do not un-
dergo metamorphosis. However, the big disadvantage of 
fish, reptiles, and birds as model systems is the lack  of  
© Baeriswyl and Stoeckli | Journal of RNAi and Gene Silencing | February 2006 | Vol 2, No 1 | 126-135 | OPEN ACCESS 
127 
genetic tools. RNAi is about to change that (Dykxhoorn 
and Lieberman, 2005). In fact, RNAi opens new possibili-
ties of gene silencing in a temporally and spatially con-
trolled manner that allows for studies that would be im-
possible with the available classical genetic tools. Spatial 
restriction can be achieved in mice by the use of sophisti-
cated CreLox technologies and inducible promoters. These 
allow for the change in gene expression in the adult mouse 
without  affecting  gene  function  during  development. 
However, there is still no way to control gene expression 
temporally in the precise manner that is required for stud-
ies of embryonic development. In this review we describe 
the advantages  of  RNAi  technology  for functional  gene 
analysis during organogenesis using the nervous system as 
an example. We discuss the advantages and disadvantages 
of different model organisms in this context. Based on its 
easy  accessibility  during  embryonic  development  the 
chicken is one of the preferred model organisms for devel-
opmental studies (Stern, 2005). The applicability of RNAi 
in chicken embryos made this model organism a perfect 
system to study gene function in a wide variety of tissues 
throughout development. 
 
ANALYSIS      OF      GENE    FUNCTION    DURING  
DEVELOPMENT OF THE NERVOUS SYSTEM 
 
The development of an organism requires a precise timing 
of gene expression in a spatially restricted manner. Many 
genes play a role in different tissues and during more than 
one time window. Excellent examples demonstrating this 
are  morphogens  (Tabata  and  Takei,  2004,  see  below). 
Morphogens  are  signaling  molecules  involved  in  very 
early aspects of development. They act in a concentration-
dependent manner on responsive cells to induce their dif-
ferentiation  to  a  particular  cell  type  (Ashe  and  Briscoe, 
2006). Morphogens include members of the hedgehog, the 
Wnt, the Fgf, and the TGFβ family. More recently, new 
roles for morphogens during later stages of development 
have  been  discovered  (Stoeckli,  2006;  Charron  and 
Tessier-Lavigne,  2005;  Zou,  2004;  Ciani  and  Salinas, 
2003;  Salinas,  2003).  These  studies  have  been  possible 
thanks  to  sophisticated  loss-of-function  approaches  in 
mice by restricting loss of gene function to a specific cell 
type (Charron et al, 2003) or by taking advantage of tem-
poral  control  of  gene  silencing  in  the  chicken  embryo 
(Bourikas et al, 2005a).  
 
Due to its complexity the nervous system takes a long time 
to develop. In fact in many species including humans neu-
ral development extends well beyond birth. It includes a 
variety of processes and genes that are involved in the de-
velopment of other organs. For instance, genes involved in 
cell migration are often the same in the developing nerv-
ous system, in the heart or the vascular system (Carmeliet 
and Tessier-Lavigne, 2005). This has often hampered the 
analysis  of  genes  by  loss-of-function  approaches  in  the 
nervous  system,  as  mouse  embryos  died  due  to  cardiac 
defects or defects in vasculogenesis and angiogenesis be-
fore their brains were fully developed. Alternatively, genes 
that have a function during several phases of embryonic 
development can only be studied during the earliest phase 
of activity, as their function during later stages is masked 
by aberrant initial development. Therefore, both classical 
reverse genetics as well as forward genetic screens have 
their limitations for the analysis of gene function during 
later stages of embryonic development. 
 
MODEL  ORGANISMS  FOR  DEVELOPMENTAL 
NEUROSCIENCE 
 
Although forward genetic approaches in invertebrate ani-
mal  models  like  Drosophila  melanogaster  and  Caenor-
habditis elegans contributed much to our understanding of 
neural development, for many questions vertebrate model 
systems are required (Anderson and Ingham, 2003). De-
pending on a developmental neuroscientist’s demands, the 
vertebrate model organism of choice has to fulfil several 
criteria including availability of techniques for gene ma-
nipulation  as  well  as  easy  accessibility  during  develop-
ment. In addition, general requirements for the usefulness 
of  a  species  as  model  organism  have  to  be  considered, 
such as the amount of money and time required for gener-
ating  mutants, the availability  in sufficient numbers and 
the easiness of husbandry of a model organism (Table 1). 
 
The mouse: From conventional knockouts to in utero 
RNAi 
The  mouse  is  the  most  widely  used  model  organism  in 
developmental neuroscience, because techniques for loss- 
and  gain-of-function  approaches  based  on  homologous 
recombination in ES cells are available (Carlson and Lar-
gaespada, 2005; Kile and Hilton, 2005). However, creating 
knockout animals by using homologous recombination in 
ES cells is still very time-consuming and cost intensive, 
and  therefore  its  usefulness  for  the  analysis  of  a  large 
number  of  genes  is  limited.  Furthermore,  conventional 
gene knockout strategies may result in embryonic lethality 
precluding the analysis of gene function in the developing 
nervous system. As mentioned above, disrupting the ex-
pression of a gene of interest early in development pre-
vents any further functional analysis at later stages because 
cell types or entire structures may not form (Chiang et al, 
1996; Ihle, 2000).  
 
To  overcome  problems  of  conventional  knockouts,  re-
combinase  systems  under  the  control  of  cell  or  tissue-
specific promoters have been developed to allow condi-
tional  gene  knockouts  in  mice  (Gawlik  and  Quaggin, 
2004).  In addition to the widely  used CreLoxP system, 
two other recombinase systems have been used success-
fully: the Flp-FRT system from Saccharomyces cerevisiae 
and the phiC31 integrase (Dymecki, 1996; Belteki et al, 
2003).  Although conditional knockout technology  using 
recombinase  systems  have  provided  insight  into  neural 
development, these strategies are limited by the require-
ment  of  cell-  or  tissue-specific  promoters  (Zhu  et  al, 
2001; Blaess et al, 2004; Lewis et al, 2004). Furthermore, 
two transgenic mouse lines are required to knockout one 
gene: One mouse line that derives the Cre recombinase 
under the control of the tissue-specific promoter, and the 
other  expressing  the  target  gene  flanked  by  loxP  sites. 
Some temporal control of gene expression in adult mice 
has been achieved with the development of tetracycline-
sensitive  and  tamoxifen-inducible  Cre  recombinase  sys-
tems (Lewandoski, 2001; Metzger and Chambon, 2001; 
Morozov et al, 2003). However, these systems do not al- 
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low short-term switches of gene expression that are re-
quired during embryonic development. 
 
Additional problems with knockout mice are genetic re-
dundancy.  Other  members  of  the  family  of  the  targeted 
gene can compensate for the loss of a gene’s function to a 
degree that silencing one gene would not result in a detect-
able loss-of-function phenotype, hence requiring the gen-
eration of double- or triple knockout mice. The difficulties 
in generating conditional double or triple knockout mice 
would  further  complicate  or  prevent  functional  gene 
analysis during development. 
 
RNA  interference  (RNAi),  a  conserved  response  to 
dsRNA resulting in specific gene silencing, represents an 
alternative  way  of  blocking  gene  expression  to  conven-
tional  and  conditional  knockout  technologies  in  mice 
(Lewis et al, 2002; McCaffrey et al, 2002; Prawitt et al, 
2004). Hasuwa and colleagues showed long-term  down-
regulation of EGFP in variety of organs of adult transgenic 
mice with a transgene-based RNAi system (Hasuwa et al, 
2002). They used the polymerase III promoter H1 to drive 
expression of an shRNA.  
 
Adenovirus-mediated RNAi resulting in specific gene si-
lencing in mouse brain has been established and offers the 
possibility for temporal control of gene silencing in adult 
mice (Xia et al, 2002). Because mouse embryos develop in 
utero they are not easily accessible during prenatal stages 
for  in  vivo  manipulations.  RNAi  in  post-implantation 
mouse embryos using electroporation has been developed 
to  knockdown  genes  during  embryonic  development 
(Calegari et al, 2002). Thus, very short-term experiments 
are  possible  because  culture  procedures  for  mouse  em-
bryos have been developed (Calegari et al, 2004). How-
ever,  the  time  window  for  these  mouse  embryo  culture 
systems is restricted to two  days and available  only for 
embryos between E7 and E13. Therefore the embryonic 
stages  that  can  be  studied  are  very  limited.  In  order  to 
study long-term functions of genes involved in brain de-
velopment in utero electroporation guided by ultrasound 
has  been  developed  for  mice  and  rats  (Takahashi  et  al, 
2002; Bai et al, 2003). In contrast to whole embryo cul-
tures, the embryos electroporated in utero can be main-
tained and analyzed from early embryonic to postnatal or 
adult stages. In utero electroporation in combination with 
RNAi has been used for the functional characterization of 
doublecortin during cortical development (Bai et al, 2003). 
Low efficiency and the requirement for expensive equip-
ment for in utero electroporation limit the wide applicabil-
ity of this approach, as does the problem of low spatial 
resolution. 
 
 
 
Table 1. Comparison of advantages and disadvantages of different loss-of-function approaches for developmental studies. The num-
ber of + or – signs indicates how much a particular issue is adding to the advantage (+) or disadvantage (–) of a particular approach. 
Obviously, the different approaches require technical expertise that cannot be taken into account for the comparison. 
 
Technique  Costs  Labtime  Temporal 
control 
Spatial 
control  Limitations 
Conventional knock-
outs (Mouse)  -  -  - -  - - -  No spatial and temporal control 
Conditional knock-
outs (Mouse)  - -  - -  -  +++ 
No temporal control 
Specific promoters required 
Inducible knockout  
(Mouse) 
- - -  - - -  ++
*  +++  Specific promoters required 
Morpholinos  
(Zebrafish)  ++  +++  -  -   
Virus-mediated 
RNAi  
(Mouse, Chicken)  
-  +  ++
*  ++   
RNAi: In utero elec-
troporation of 
si/shRNA (Mouse, 
Rats) 
+   +  ++  -  Poor spatial resolution 
In ovo RNAi  
(Chicken)  +++  +++  +++
  +++  Embryonic stages only 
 
*Temporal control is not available for embryonic stages 
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The Zebrafish as a model organism for developmental 
neuroscience 
The zebrafish is a small tropical fish that represents an al-
ternative vertebrate model organism to the mouse because 
of its rapid development ex utero. Embryos are translucent 
and therefore ideal for in vivo imaging. Improved methods 
for mutagenesis, transgenesis and gene targeting increase 
the usefulness of  the  zebrafish as  a model  organism  for 
functional genomics (Ekker, 1999; Patton and Zon, 2001; 
Udvadia and Linney, 2003). Although chemical screens are 
highly effective in generating loss-of-function mutants, the 
process of identifying the mutated gene is laborious (Zhang 
et al, 1998; Talbot and Schier, 1999). Furthermore, as men-
tioned above, forward genetic approaches may not be use-
ful for specific questions and do not allow for spatiotempo-
ral control of gene silencing. 
 
Antisense technology is a useful tool for specific gene si-
lencing during development and has been applied in many 
species (Audic et al, 2001; Coonrod et al, 2001; Howard et 
al,  2001;  Yang  et  al,  2001;  Kos  et  al,  2003).  Chemical 
modification of oligonucleotides has improved their stabil-
ity and therefore increased their applicability in vivo. Mor-
pholino  phosphorodiamidate  oligonucleotide-mediated 
gene inactivation is widely used for the analysis of gene 
function  in  zebrafish  (Summerton  and  Weller,  1997; 
Nasevicius  and  Ekker,  2000;  Corey  and  Abrams,  2001; 
Heasman, 2002; Sumanas and Larson, 2002). Morpholinos 
show a lower cellular toxicity and fewer side effects com-
pared to conventional antisense nucleotides (Pickart et al, 
2004). Usually morpholinos are microinjected into zebraf-
ish embryos between the one- and the eight-cell stage. For 
effective gene inactivation the morpholino has to be com-
plementary to the 5’UTR or the translation initiation site 
(Summerton and Weller, 1997; Heasman, 2002). The de-
gree of gene silencing depends on the injected morpholino 
concentration and the extent of dilution due to cell prolif-
eration (Heasman, 2002). Because morpholinos have to be 
injected into zebrafish embryos at very early developmental 
stages they loose effectiveness after a few days. Thus, func-
tional analysis of genes expressed at later developmental 
stages cannot be achieved by this approach. The use of high 
concentrations of morpholinos increases the risk of induc-
ing non-specific and toxic effects including cell death and 
neural degeneration (Nasevicius and Ekker, 2000; Braat et 
al, 2001; Karlen and Rebagliati, 2001; Lele et al, 2001). 
Lipofection can be used to improve cellular penetration of 
antisense oligonucleotides in vitro as well as in vivo (Juli-
ano et al, 1999; Stenkamp et al, 2000). However, lipofec-
tion is associated with toxicity in vitro and even more im-
portantly in vivo. 
 
In  ovo  RNAi  -  a  tool  for  functional  gene  analysis  in 
chicken embryos allows for temporal control of gene 
silencing  
For a long time the chicken embryo was a classical model 
organism for developmental studies in vertebrates because 
of its easy accessibility during development (Bourikas and 
Stoeckli, 2003; Bourikas et al, 2005b; Stern, 2005). In ovo 
as well as ex ovo culture methods of chicken embryos of-
fer  the  possibility  for  in  vivo  manipulations  throughout 
embryonic  development  (Perry,  1988;  Stoeckli,  2003; 
Krull, 2004; Luo and Redies, 2005). After 21 days, at the 
time of hatching, the nervous system is fully developed and 
functional.  The  chicken  genome  is  sequenced,  and  thus, 
comparisons  of  chicken  genes  with  the  human  and  the 
mouse or rat genomes are very easy (Hillier et al, 2004). 
 
Due to biological constraints and the lack of ES cells it is 
not possible to manipulate the chicken genome with the 
same toolkit that is available for the mouse. The technol-
ogy to generate transgenic chickens has been developed 
very recently (Mozdziak et al, 2003; Chapman et al, 2005), 
but the size and the long generation time of chickens limit 
the feasibility to breed them in a lab animal facility. 
 
The easy accessibility of the chicken embryo during devel-
opment of the nervous system was exploited for functional 
studies at the protein level using function-blocking antibod-
ies (Stoeckli and Landmesser, 1995; Stoeckli et al, 1997; 
Burstyn-Cohen et al, 1999; Perrin et al, 2001). However, 
the limited availability of function-blocking antibodies se-
verely restricted the usefulness of this approach. As an al-
ternative, viral vector-based expression systems were de-
veloped  to  express  dominant-negative  proteins  (Morgan 
and Fekete, 1996; Logan and Tabin, 1998). Morpholinos 
were also used successfully in chicken embryos (Kos et al, 
2003; Tucker, 2004), although they may be more difficult 
to  target to specific  tissues than  regular oligonucleotides 
(Krull, 2004). More recently, in ovo electroporation as an 
efficient method of gene transfer in chicken embryos for 
the temporally and spatially controlled ectopic expression 
of a gene of interest was established (Table 2; Muramatsu 
et al, 1997; Momose et al, 1999; Nakamura and Funahashi, 
2001; reviewed in Bourikas and Stoeckli, 2003). Because 
loss-of-function phenotypes are usually more informative 
than gain-of-function phenotypes for the functional charac-
terization of a gene of interest (Hudson et al, 2002) both 
viral vector-mediated and electroporation-based gene trans-
fer  depended  on  the  availability  of  a  dominant-negative 
mutant of the gene of interest.  
 
To overcome the limitations of the chicken embryo as a 
model system for functional gene analysis, in ovo RNAi, a 
combination of in ovo electroporation for efficient nucleic 
acid  transfer  and  RNAi  for  specific  gene  silencing  has 
been established (Figure 1; Pekarik et al, 2003; Stoeckli, 
2003; Bron et al, 2004; Krull, 2004).  
 
Gene silencing has been achieved with several approaches 
and in many different areas of the nervous system (Table 
2) but also other tissues (e.g. Toyofuku et al, 2004). The 
parameters for electroporation have to be adapted to the 
age of the embryo and the target tissue (Itasaki et al, 1999; 
Krull, 2004; Luo and Redies, 2004). More important than 
the electroporator (see Krull, 2004, for a comparison  of 
different brands) is the choice of electrodes. For a focal 
transfer of nucleic acids a needle electrode is often placed 
directly into the tissue (Oberg et al, 2002; Luo and Redies, 
2004).  For  a  more  widespread  transfer  a  non-invasive 
method with wire or platelet electrodes is chosen (Dai et 
al, 2005; Nakamura et al, 2004; Toyofuku et al, 2004; Ma-
tsuda and Cepko, 2004). Some researchers found sonopo-
ration more effective than electroporation for nucleic acid 
transfer into mesenchymal tissue (Ohta et al, 2003, but see 
Swartz et al, 2001a; Eberhart et al, 2004).  
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Table 2. In ovo electroporation or RNAi has been successfully used to change gene expression in chicken embryos in a temporally 
and spatially controlled manner. 
 
 
Loss of function by  Target tissue 
dsRNA
1  siRNA  shRNA 
Gain of 
function  Reference 
    x    Chesnutt and Niswander, 2004 
Dai et al, 2005 
  x  x    Bron et al, 2004 
x  x  x    Rao et al, 2004 
x       
Pekarik et al, 2003 
Bourikas et al, 2005a 
Stepanek et al, 2005 
Neural tube 
 
      x  Luo and Redies, 2005 
 
    x    Katahira and Nakamura, 2003   
Cranial neural 
tube     
x      Nakamura et al, 2004 
Cerebellum   
      x  Luo and Redies, 2004 and 2005 
Tectum   
    x    Yamagata and Sanes, 2005 
Retina, lens     
    x  Chen et al, 2004 
Limbs, mesen-
chyme        x
2 
Swartz et al, 2001a,b 
Eberhart et al, 2002 
Oberg et al, 2002; 
Krull, 2004 
Somites         x 
Swartz et al, 2001a, b 
Eberhart et al, 2002 
Scaal et al, 2004 
Heart   
  x      Toyofuku et al, 2004 
 
Note: Detailed protocols can be found in: Stoeckli, 2003; Krull, 2004; Sato et al, 2004 
1 dsRNA refers to the use of long fragments of dsRNA (200 – 2000 bp) 
2 In some studies dominant-negative proteins were expressed to get loss-of-function phenotypes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. In ovo RNAi is an efficient method to silence genes in a temporally and spatially controlled manner in the developing neu-
ral tube. The chicken embryo can be accessed through a window cut into the eggshell. Phosphate-buffered saline containing long 
dsRNA, siRNA, or a plasmid encoding shRNA and 0.04% Trypan Blue is injected into the neural tube of the developing embryo 
with a glass pipette (A). In order to visualize the area where the injected RNA was taken up or as a control a plasmid encoding GFP 
can be co-injected. Wire electrodes are positioned parallel to the longitudinal axis of the embryo. Due to the negative charge of the  
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nucleic acids cells toward the side of the anode are transfected. On average, we achieved 60% transfection efficiency in the targeted 
area of the neural tube of a 3-day-old embryo using 5 pulses of 25 Volts and of 50 msec duration (Pekarik et al, 2003). We use a one 
second inter-pulse interval. Depending on the position of the electrodes the target area can be selected. Positioning the electrodes 
dorsally will only target dorsal cell of the developing neural tube, whereas a more ventral position will result in transfected cells all 
along the dorso-ventral axis (as shown in B). To analyze the resulting phenotypes induced by knockdown of the target gene a variety 
of methods can be used. As an example we illustrate visualizing the trajectory of dorsolateral commissural neurons. These neurons 
extend their axons toward the floor plate, the structure that forms the ventral midline of the spinal cord. Axons cross the ventral mid-
line before turning rostrally along the contralateral side of the floor plate (Bourikas et al, 2005a). The trajectory of these axons can be 
visualized by application of the lipophilic dye DiI to the cell bodies of commissural neurons (C). The comparison between control 
embryos, injected with a plasmid encoding GFP only or a control siRNA, with embryos injected with the target-specific dsRNA 
would reveal phenotypes in axon pathfinding. In the situation shown here, these would be caused by cell non-autonomous functions 
of the target gene as commissural axons from the side contralateral to the electroporated area are traced. For detailed protocols see 
references in Table 2. 
 
 
In contrast to mammalian cell lines and non-embryonic tis-
sue long dsRNA can be used in chicken embryos without 
induction of unspecific effects. No general inhibition of pro-
tein synthesis or induction of apoptosis has been observed 
(Pekarik et al, 2003; Chesnutt and Niswander, 2004). Simi-
larly,  no  unspecific  effects  were  seen  in  mouse  oocytes 
(Stein et al, 2005) and cell lines derived from embryonic 
tissue (Billy et al, 2001). To avoid unspecific effects in post-
natal mice and cell lines short interfering RNAs (siRNAs) 
can be used (Caplen et al, 2001; Elbashir et al, 2001). They 
have  been  successfully  used  in  chicken  embryos  as  well 
(Katahira and Nakamura, 2003; Sato et al, 2004). 
 
As electroporation does not affect 100% of the cells in the 
target area (Pekarik et al, 2003; Luo and Redies, 2005) it 
may be important to identify those cells that did take up 
the  siRNA  or  the  dsRNA.  In  many  cases  co-
electroporation of a plasmid encoding EGFP has been cho-
sen and was sufficient (Pekarik et al, 2003; Nakamura et 
al, 2004). However, for an unequivocal identification of 
transfected cells the  use  of a vector-based approach  has 
been  developed.  Driven  by  a  polymerase  III  promoter 
short-hairpin  RNAs  (shRNAs)  are  produced  in  the  cell. 
Because the plasmid contains an IRES site and also en-
codes EGFP all transfected cells are easily identified. The 
commonly used pol III promoters H1 and U6 were found 
to work well in chicken embryos (Katahira and Nakamura, 
2003;  Chesnutt and Niswander, 2004; Bron et al, 2004; 
Dai et al, 2005). 
 
No matter whether long dsRNA, siRNAs, or shRNAs are 
used, the knockdown of target genes has been found to be 
efficient. Obviously, RNAi only prevents the synthesis of 
new  protein.  It  cannot  remove  the  pre-existing  protein 
from a cell. Thus, for most  effective gene silencing the 
injection and electroporation has to be carried out before 
the onset of gene expression. Gene silencing by RNAi was 
found to be long lasting in non-proliferating cells (from at 
least 9 days to 3 weeks; Sato et al, 2004; Omi et al, 2004). 
In cell culture or in tissues where cells proliferate the ef-
fect is diluted with successive cell divisions and usually 
decreases after 3-5 days. The use of a mixture of 3-5 dif-
ferent siRNAs is generally considered to be more effective 
than the use of a single siRNA. For that purpose mixtures 
of siRNAs can be generated in vitro from long dsRNAs by 
digestion with RNase ONE (Rao et al, 2004). The produc-
tion of siRNAs in situ from vectors encoding shRNAs was 
found to extend the length of gene silencing compared to 
siRNAs (Bron et al, 2004). 
As mentioned above, it is not necessary to generate the mix-
ture of siRNAs in vitro before injection as long as embry-
onic tissue is used. Long dsRNA was always effective in 
gene silencing in our hands, presumably because they al-
ways give rise to a mixture of siRNAs that contains many 
effective ones. If siRNAs are designed with algorithms that 
are either freely available (Ui-Tei et al, 2004; Nakamura et 
al,  2004)  or  commercially  used  by  companies  selling 
siRNAs, it can still be frustrating to find effective ones. 
 
Concerns about so-called off-target effects, i.e. the silenc-
ing of one or several non-target genes due to full or partial 
sequence homology with the siRNA have been raised (re-
viewed in Jackson and Linsley, 2004). Obviously such an 
event cannot be fully excluded but there are some rules to 
minimize the risk of off-target effects (Qiu et al, 2005). 
Firstly, it is of course essential to carry out proper BLAST 
analyses and to avoid sequences that are found in genes 
other than the target gene. Secondly, more than one (mix-
ture of) siRNA or long dsRNA fragment should be used 
independently, as it is unlikely that they would have the 
same  off-target  effect,  i.e.  silence  the  same  non-target 
genes. Thirdly, the concentration of the siRNA should be 
as low as possible. Generally,  unspecific effects are not 
expected when concentrations are 20 nM or lower. When 
using  long  dsRNA  we  routinely  get  effective  silencing 
with dsRNA concentrations in the range of 0.1-1 nM. 
 
It is difficult to compare the efficiency  of gene silencing 
between different RNAi approaches in the absence of sys-
tematic studies. The percentage of gene knockdown corre-
lates with the concentration of siRNA, or dsRNA, respec-
tively.  Rao  and  colleagues  compared  the  efficiency  of 
siRNAs with a mixture of siRNAs produced in vitro from 
long dsRNA by RNase ONE, and long dsRNA (Rao et al, 
2004).  They  concluded  that  siRNAs  were  more  effective 
than  the  mixture  of  siRNAs  created  in  vitro  and  long 
dsRNA, respectively. However, this conclusion is flawed by 
the fact that the number of effective siRNAs created from 
long dsRNA in vivo or in vitro by RNase ONE (where also 
ineffective siRNAs shorter than 21 bp are generated) is un-
known. They used the same amount of siRNAs (200 ng/µl) 
and long dsRNA (700 bp fragment). Therefore, the concen-
tration of the long dsRNA was roughly 30fold lower than 
the concentration of siRNAs. The effect of the much lower 
concentration of long dsRNA was still more than half as 
efficient as the siRNAs (53% compared to 90%), thus rais-
ing some doubts, whether siRNAs are really more efficient 
than long dsRNA.  
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The major advantages of in ovo RNAi are the temporal 
and spatial control of gene expression. This is due to the 
accessibility of the chicken embryo in ovo and the possi-
bility  to  culture  embryos  ‘shell-less’  in  dishes  (Perry, 
1988; Luo and Redies, 2005). Furthermore, it is easy to 
knockdown more than one gene at the same time. Full-
length  cloning  is  not  required,  as  cDNA  fragments  or 
ESTs can directly be used to produce dsRNA by in vitro 
transcription. Therefore, in ovo RNAi represents a fast and 
inexpensive tool for functional genomics. It can easily be 
adapted  for  the  assessment  of  different  developmental 
processes (Table  2;  Bourikas and  Stoeckli,  2003;  Krull, 
2004; Eberhart et al, 2004; Toyofuku et al, 2004; Luo and 
Redies, 2004 and 2005; Luo et al, 2004). 
 
Taking advantage of the major asset of in ovo RNAi, i.e. 
precise temporal control over gene silencing during em-
bryonic  development,  a  role  for  the  morphogen  sonic 
hedgehog (SHH) in postcommissural axon guidance could 
recently be demonstrated (Bourikas et al, 2005a). During 
early stages of embryonic development SHH is involved in 
inductive  and  patterning  processes  including  control  of 
left-right asymmetry and formation of the limb (reviewed 
by Marti and Bovolenta, 2002; Jacob and Briscoe, 2003). 
Slightly  later in development,  Shh  was  shown  to act in 
parallel to netrin-1 as a chemoattractant for dorsal com-
missural axons (Charron et al, 2003). All these effects of 
Shh  are  mediated  by  a  receptor  complex  composed  of 
Patched and Smoothened. Interestingly, these receptors are 
not  involved  in  Shh’s effect  on postcommissural axons. 
After crossing the floor plate, the ventral midline of the 
spinal cord, commissural axons are no longer expressing 
Patched and Smoothened. The repulsive effect of Shh on 
postcommissural  axons  is  mediated  by  Hip  (Hedgehog 
interacting protein). Thus, commissural axons switch from 
being attracted by Shh before midline crossing to  being 
repelled by  a concomitant  switch in receptor expression 
(Figure 2; Bourikas et al, 2005a; reviewed by Charron and 
Tessier-Lavigne, 2005). The analysis of this rapid change 
in  responsiveness  to  Shh  would  not  have  been  possible 
without a method that allows for precise temporal control 
of gene silencing. 
 
The  large  number  of  papers  describing  various  ap-
proaches of RNAi-based gene silencing in chicken em-
bryos demonstrates the versatility of the chicken embryo 
on the one hand and RNAi on the other hand. We have 
only been able to include some of the studies carried out 
in the last 2 to 3 years and focused largely on the devel-
opment  of  the  nervous  system.  The  multitude  of  ap-
proaches, siRNAs versus shRNAs or long dsRNA, dif-
ferent electrodes used with different electroporation pa-
rameters  may  be  confusing  at  first  glance.  However, 
transfection of a plasmid encoding GFP is an easy way to 
get started. It allows for fast assessment of transfection 
efficiency in the target area and for selection of experi-
mental parameters. Above all, it provides a fast method 
to test and train the skills of the experimenter to handle 
chicken embryos in ovo or ex ovo. Beginners should use 
GFP expression to assess their skills with respect to re-
producibility of electroporation and the absence of arte-
facts  due  to  tissue  damage  caused  by  injection  or  by 
touching embryonic tissue with the electrodes. The fact 
that both in ovo RNAi and ex ovo RNAi require some 
manual skills for handling live embryos may in fact rep-
resent their biggest disadvantage. The best way to learn 
handling chicken embryos is by visiting a lab where they 
are routinely used for research. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. In ovo RNAi allows for temporal control of gene silencing in the developing neural tube. In order to study gene function 
during embryonic development precise temporal and spatial control of gene silencing is required. Classical knock-out strategies do 
not allow for functional gene analysis during later stages of development, as lack of target gene expression during the first time win-
dow would preclude the analysis of its function during later stages. An example illustrating the requirement for temporal control is 
the analysis of SONIC HEDGEHOG (SHH). Shh is a morphogen that is required for differentiation of cells in the spinal cord during 
early stages of development (Jessell, 2000). Slightly later, Shh acts in parallel to Netrin-1 as a long-range guidance cue, attracting 
dorsal commissural axons toward the floor plate (A; Charron et al, 2003). This attractive effect of Shh is mediated by the co-receptor 
formed by Patched and Smoothened (Smo). A few hours later, after commissural axons have crossed the floor plate, Shh acts as a 
repulsive guidance cue, directing post-commissural axons rostrally (B; Bourikas et al, 2005a). The repulsive activity of Shh is medi-
ated by Hedgehog-interacting protein (Hip). Thus, within a short period of time, commissural axons switch receptors (from Smo to 
Hip) that allow them to respond differently to Shh gradients.  
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CONCLUSIONS 
 
The development of in ovo RNAi has not only reinstated 
the importance of the chicken embryo as a model organ-
ism for developmental studies but it has added precise 
temporal control of gene silencing to our toolkit for gene 
manipulations. As demonstrated in recent studies, tem-
poral and spatial control of gene function is an important 
aspect  of  functional  gene  analysis  during  embryonic 
development. 
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